A/Prof Craig L Fry
A/Prof Craig L Fry
National Evaluation Manager, Royal Australian College of General Practitioners.
Verified email at - Homepage
Cited by
Cited by
Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia
K Dolan, Jo Kimber, Craig Fry, David McDonald, John Fitzgerald, Franz Trautmann
Drug and alcohol review 19 (3), 337-346, 2000
For love or money? An exploratory study of why injecting drug users participate in research
C Fry, R Dwyer
Addiction 96 (9), 1319-1325, 2001
Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?
RA Jenkinson, NC Clark, CL Fry, M Dobbin
Addiction 100 (2), 197-205, 2005
Australian drug trends 2001: Findings of the illicit drug reporting system (IDRS)
L Topp, S Kaye, RB Bruno, M Longo, P Williams, B O'Reilly, CL Fry, ...
University of New South Wales, 2002
Transient changes in behaviour lead to heroin overdose: results from a case‐crossover study of non‐fatal overdose
P Dietze, D Jolley, C Fry, G Bammer
Addiction 100 (5), 636-642, 2005
Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia
L Degenhardt, L Degenhardt, E Black, L Degenhardt, E Black, C Breen, ...
Drug and Alcohol Review 25 (5), 403-412, 2006
The ethics of paying drug users who participate in research: a review and practical recommendations
CL Fry, W Hall, A Ritter, R Jenkinson
Journal of Empirical Research on Human Research Ethics 1 (4), 21-35, 2006
Paying research participants: a study of current practices in Australia
CL Fry, A Ritter, S Baldwin, KJ Bowen, P Gardiner, T Holt, R Jenkinson, ...
Journal of medical ethics 31 (9), 542-547, 2005
The ethics of reimbursing injecting drug users for public health research interviews: what price are we prepared to pay?
AJ Ritter, CL Fry, A Swan
International Journal of Drug Policy 14, 1-3, 2003
A survey of regular ecstasy users’ knowledge and practices around determining pill content and purity: Implications for policy and practice
J Johnston, MJ Barratt, CL Fry, S Kinner, M Stoové, L Degenhardt, ...
International Journal of Drug Policy 17 (6), 464-472, 2006
Victorian drug trends 2003: Findings from the illicit drug reporting system (IDRS)
R Jenkinson, P Miller, CL Fry
University of New South Wales, 2004
Drug and alcohol treatment providers’ views about the disease model of addiction and its impact on clinical practice: A systematic review
AI Barnett, W Hall, CL Fry, E Dilkes‐Frayne, A Carter
Drug and alcohol review 37 (6), 697-720, 2018
Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics
CL Fry, C Treloar, L Maher
Drug and alcohol review 24 (5), 449-459, 2005
When is a little knowledge dangerous?: circumstances of recent heroin overdose and links to knowledge of overdose risk factors
P Dietze, D Jolley, CL Fry, G Bammer, D Moore
Drug and Alcohol Dependence 84 (3), 223-230, 2006
Establishing safe injecting rooms in Australia: attitudes of injecting drug users
C Fry, S Fox, G Rumbold
Australian and New Zealand Journal of Public Health 23 (5), 501-504, 1999
Realising the technological promise of smartphones in addiction research and treatment: an ethical review
H Capon, W Hall, C Fry, A Carter
International Journal of Drug Policy 36, 47-57, 2016
Intentional overdose among heroin overdose survivors
P Heale, P Dietze, C Fry
Journal of Urban Health 80 (2), 230-237, 2003
Ethical questions must be considered for electronic health records
M Spriggs, MV Arnold, CM Pearce, C Fry
Journal of Medical Ethics 38 (9), 535-539, 2012
Positive and negative aspects of participation in illicit drug research: implications for recruitment and ethical conduct
MJ Barratt, JS Norman, CL Fry
International Journal of Drug Policy 18 (3), 235-238, 2007
Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake
CL Fry
International Journal of Drug Policy 13 (6), 471-476, 2002
The system can't perform the operation now. Try again later.
Articles 1–20